Shares of Axcelis Technologies Inc (NASDAQ:ACLS) have been given a consensus rating of “Buy” by the six research firms that are covering the firm. One research analyst has rated the stock with a hold recommendation, four have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $18.30.

A number of research firms recently weighed in on ACLS. B. Riley reaffirmed a “buy” rating and set a $19.00 price target on shares of Axcelis Technologies in a report on Wednesday, January 11th. Zacks Investment Research raised Axcelis Technologies from a “hold” rating to a “strong-buy” rating and set a $19.00 price target for the company in a report on Monday, February 6th. Benchmark Co. reaffirmed a “buy” rating and set a $18.50 price target on shares of Axcelis Technologies in a report on Thursday, February 2nd. Stifel Nicolaus cut Axcelis Technologies from a “buy” rating to a “hold” rating and set a $16.00 price target for the company. in a report on Friday, January 13th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $18.00 price target on shares of Axcelis Technologies in a report on Tuesday, January 31st.

Your IP Address:

In related news, VP Lynnette C. Fallon sold 37,500 shares of the firm’s stock in a transaction on Tuesday, February 7th. The stock was sold at an average price of $16.45, for a total transaction of $616,875.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP William J. Bintz sold 20,250 shares of the firm’s stock in a transaction on Thursday, February 16th. The shares were sold at an average price of $16.01, for a total value of $324,202.50. Following the sale, the executive vice president now directly owns 44,476 shares of the company’s stock, valued at $712,060.76. The disclosure for this sale can be found here. Insiders have sold a total of 107,624 shares of company stock valued at $1,763,500 over the last ninety days. Insiders own 5.13% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. Metropolitan Life Insurance Co. NY boosted its stake in Axcelis Technologies by 11.1% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 20,593 shares of the company’s stock worth $300,000 after buying an additional 2,060 shares in the last quarter. Symmetry Peak Management LLC acquired a new stake in Axcelis Technologies during the third quarter worth $232,000. State Street Corp boosted its stake in Axcelis Technologies by 4.4% in the fourth quarter. State Street Corp now owns 495,084 shares of the company’s stock worth $7,205,000 after buying an additional 20,751 shares in the last quarter. GSA Capital Partners LLP boosted its stake in Axcelis Technologies by 43.2% in the fourth quarter. GSA Capital Partners LLP now owns 109,372 shares of the company’s stock worth $1,591,000 after buying an additional 33,000 shares in the last quarter. Finally, Guggenheim Capital LLC boosted its stake in Axcelis Technologies by 502.2% in the fourth quarter. Guggenheim Capital LLC now owns 69,036 shares of the company’s stock worth $1,004,000 after buying an additional 57,572 shares in the last quarter. 71.74% of the stock is owned by hedge funds and other institutional investors.

Shares of Axcelis Technologies (NASDAQ:ACLS) opened at 16.05 on Thursday. The firm has a market capitalization of $473.75 million, a price-to-earnings ratio of 44.58 and a beta of 1.32. Axcelis Technologies has a 12 month low of $8.92 and a 12 month high of $16.95. The stock’s 50 day moving average price is $15.69 and its 200-day moving average price is $14.16.

Axcelis Technologies (NASDAQ:ACLS) last released its quarterly earnings results on Wednesday, February 1st. The company reported $0.13 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.10 by $0.03. Axcelis Technologies had a return on equity of 5.65% and a net margin of 4.12%. The firm earned $69.40 million during the quarter, compared to analysts’ expectations of $68.82 million. During the same period last year, the firm posted $0.01 EPS. The business’s revenue was down 1.6% on a year-over-year basis. On average, equities research analysts predict that Axcelis Technologies will post $0.93 EPS for the current fiscal year.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The Company operates through the manufacture of capital equipment for the semiconductor manufacturing industry segment. The Company sells its equipment to semiconductor chip manufacturers across the world.

5 Day Chart for NASDAQ:ACLS

Receive News & Stock Ratings for Axcelis Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies Inc and related stocks with our FREE daily email newsletter.